DALFAMPRIDINE for Ill-defined disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where DALFAMPRIDINE was used for Ill-defined disorder.
Most Reported Side Effects for DALFAMPRIDINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gait disturbance | 8,780 | 15.6% | 35 | 815 |
| Drug ineffective | 6,794 | 12.1% | 20 | 341 |
| Fall | 5,554 | 9.9% | 48 | 1,483 |
| Therapy cessation | 4,580 | 8.2% | 27 | 594 |
| Fatigue | 3,778 | 6.7% | 29 | 441 |
| Balance disorder | 3,753 | 6.7% | 9 | 366 |
| Multiple sclerosis relapse | 3,322 | 5.9% | 29 | 1,234 |
| Condition aggravated | 3,240 | 5.8% | 25 | 409 |
| Dizziness | 2,959 | 5.3% | 5 | 256 |
| Urinary tract infection | 2,757 | 4.9% | 37 | 917 |
| Insomnia | 2,546 | 4.5% | 12 | 165 |
| Mobility decreased | 2,512 | 4.5% | 14 | 262 |
| Asthenia | 2,360 | 4.2% | 36 | 551 |
| Headache | 2,241 | 4.0% | 10 | 206 |
| Multiple sclerosis | 2,224 | 4.0% | 89 | 537 |
Other Indications for DALFAMPRIDINE
Multiple sclerosis (28,787)
Product used for unknown indication (17,590)
Gait disturbance (13,663)
Balance disorder (298)
Relapsing-remitting multiple sclerosis (155)
Muscular weakness (100)
Asthenia (94)
Secondary progressive multiple sclerosis (85)
Fatigue (83)
Mobility decreased (74)
Other Drugs Used for Ill-defined disorder
IBUPROFEN (707)
ATORVASTATIN (570)
DAPAGLIFLOZIN (556)
SERTRALINE (437)
AMLODIPINE (415)
ROSUVASTATIN (361)
OMEPRAZOLE (272)
DOXYCYCLINE (254)
PREGABALIN (248)
LANSOPRAZOLE (227)